These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38610011)

  • 1. "In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.
    Orellana M; DSouza KN; Yap JQ; Sriganeshan A; Jones ME; Johnson C; Allyse M; Venable S; Stewart EA; Enders F; Balls-Berry JE
    BMC Womens Health; 2024 Apr; 24(1):233. PubMed ID: 38610011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.
    Orellana M; Riggan KA; DSouza K; Stewart EA; Venable S; Balls-Berry JE; Allyse MA
    J Racial Ethn Health Disparities; 2022 Aug; 9(4):1184-1191. PubMed ID: 34013445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Environment, Leiomyomas, Latinas, and Adiposity Study: rationale and design.
    Manuel EC; Plowden TC; Valbuena FM; Bryce RL; Barick AA; Ramakrishnan A; Carnethon MR; Neff LM; Baird DD; Marsh EE
    Am J Obstet Gynecol; 2022 Mar; 226(3):392.e1-392.e12. PubMed ID: 33974903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Altered Perception of Normal: Understanding Causes for Treatment Delay in Women with Symptomatic Uterine Fibroids.
    Ghant MS; Sengoba KS; Vogelzang R; Lawson AK; Marsh EE
    J Womens Health (Larchmt); 2016 Aug; 25(8):846-52. PubMed ID: 27195902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
    Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
    J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black Women's Psychosocial Experiences with Seeking Surgical Treatment for Uterine Fibroids: Implications for Clinical Practice.
    VanNoy BN; Bowleg L; Marfori C; Moawad G; Zota AR
    Womens Health Issues; 2021; 31(3):263-270. PubMed ID: 33610438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health.
    Ghant MS; Sengoba KS; Recht H; Cameron KA; Lawson AK; Marsh EE
    J Psychosom Res; 2015 May; 78(5):499-503. PubMed ID: 25725565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family History and Uterine Fibroid Development in Black and African American Women.
    Langton CR; Harmon QE; Baird DD
    JAMA Netw Open; 2024 Apr; 7(4):e244185. PubMed ID: 38568693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year symptom severity and health-related quality of life changes among Black African patients undergoing uterine fibroid embolisation.
    Mariara C; Obura T; Hacking N; Stones W
    BMC Res Notes; 2017 Jul; 10(1):240. PubMed ID: 28676073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.
    Baird DD; Saldana TM; Shore DL; Hill MC; Schectman JM
    Hum Reprod; 2015 Dec; 30(12):2936-44. PubMed ID: 26409013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
    Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE
    Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of Fibroids on Transvaginal Ultrasonography in a Community-Based, Diverse Cohort of 996 Reproductive-Age Female Participants.
    Huang D; Magaoay B; Rosen MP; Cedars MI
    JAMA Netw Open; 2023 May; 6(5):e2312701. PubMed ID: 37163265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genital talc and douche use in early adolescence or adulthood with uterine fibroids diagnoses.
    Ogunsina K; Sandler DP; Murphy JD; Harmon QE; D'Aloisio AA; Baird DD; O'Brien KM
    Am J Obstet Gynecol; 2023 Dec; 229(6):665.e1-665.e10. PubMed ID: 37598998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy-Based Infant Formula Feeding and Uterine Fibroid Development in a Prospective Ultrasound Study of Black/African-American Women.
    Langton CR; Harmon QE; Upson K; Baird DD
    Environ Health Perspect; 2023 Jan; 131(1):17006. PubMed ID: 36696103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.